{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:30:45Z","timestamp":1751463045041},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1987,11,1]],"date-time":"1987-11-01T00:00:00Z","timestamp":562723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1987,11,1]],"date-time":"1987-11-01T00:00:00Z","timestamp":562723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1987,11,1]],"date-time":"1987-11-01T00:00:00Z","timestamp":562723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1987,11,1]],"date-time":"1987-11-01T00:00:00Z","timestamp":562723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metast Rev"],"published-print":{"date-parts":[[1987,11]]},"DOI":"10.1007\/bf00144268","type":"journal-article","created":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T03:48:41Z","timestamp":1099280921000},"page":"283-300","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hairy cell leukemia: clinical features and therapeutic advances"],"prefix":"10.1007","volume":"6","author":[{"given":"Barry C.","family":"Lembersky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey M.","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00144268_CR1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","volume":"13","author":"BA Bouroncle","year":"1958","unstructured":"Bouroncle BA, Wiseman BK, Doan CA: Leukemic reticuoendotheliosis. Blood 13: 609\u2013629, 1958","journal-title":"Blood"},{"key":"BF00144268_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.1978.tb05822.x","volume":"40","author":"D Hernandez","year":"1978","unstructured":"Hernandez D, Cruz C, Carnot J, Dorticos E, Espenosa E: Hairy cell leukemia of T-cell origin. Br J Hematol 40: 504\u2013506, 1978","journal-title":"Br J Hematol"},{"key":"BF00144268_CR3","first-page":"446","volume":"11","author":"W Wachsman","year":"1984","unstructured":"Wachsman W, Golde DW, Chen IS: Hairy cell leukemia and human T cell leukemia virus. Sem Oncol 11: 446\u2013449, 1984","journal-title":"Sem Oncol"},{"key":"BF00144268_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2141.1979.tb01122.x","volume":"4","author":"EP Reiber","year":"1979","unstructured":"Reiber EP, Hadan MR, Leake RP, Sool JG, Riethmuller G, VonHeyden HW, Waller HD: Hairy cell leukemia: Surface markers and functional capabilities of the leukemic cell analyzed in eight patients. Br J Hematol 4: 175\u2013188, 1979","journal-title":"Br J Hematol"},{"key":"BF00144268_CR5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V59.1.52.52","volume":"59","author":"J Jansen","year":"1982","unstructured":"Jansen J, Schuit HRE, Meijer CJ, VanNicuwkoop JA, Hijmans W: Cell markers in hairy cell leukemia studied in cells from 51 patients. Blood 59: 52\u201360, 1982","journal-title":"Blood"},{"key":"BF00144268_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V59.3.609.609","volume":"59","author":"J Jansen","year":"1982","unstructured":"Jansen J, LeBien TW, Kersey J: The phenotype of neoplastic cells of hairy cell leukemia studied with monoclonal antibodies. Blood 59: 609\u2013614, 1982","journal-title":"Blood"},{"key":"BF00144268_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcp\/79.4.431","volume":"79","author":"AJ Janckila","year":"1983","unstructured":"Janckila AJ, Stelzer GT, Wallace JH: Phenotype of the hairy cells of leukemic reticuloendotheliosis defined by monoclonal antibodies. Am J Clin Pathol 79: 431\u2013437, 1983","journal-title":"Am J Clin Pathol"},{"key":"BF00144268_CR8","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1073\/pnas.80.14.4522","volume":"80","author":"SJ Korsmeyer","year":"1983","unstructured":"Korsmeyer SJ, Greene WC, Gossman J, Hsu SM, Jensen JP, Neckers LM, Marshall SL, Bakhshi A, Depper JM, Leonard WJ, Jaffe ES, Waldman TA: Rearrangement and expression of immunologlobulin genes and expression of TAC antigen in hairy cell leukemia. Proc Natl Acad Sci 80: 4522\u20134526, 1983","journal-title":"Proc Natl Acad Sci"},{"key":"BF00144268_CR9","first-page":"394","volume":"11","author":"SJ Korsmeyer","year":"1984","unstructured":"Korsmeyer SJ, Greene WC, Waldmann TA: Cellular origin of hairy cell leukemia: Malignant B cells that express receptors for T cell growth factor. Semin in Oncol 11: 394\u2013400, 1984","journal-title":"Semin in Oncol"},{"key":"BF00144268_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.4049\/jimmunol.129.4.1398","volume":"129","author":"HJ Liebson","year":"1982","unstructured":"Liebson HJ, Marrack P, Kappler JW: B-cell helper factors: I. Requirement for both interleukin-2 and another 40.000 molecular weight factor. J Immunol 129: 1398\u20131402, 1982","journal-title":"J Immunol"},{"key":"BF00144268_CR11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1182\/blood.V65.3.620.620","volume":"65","author":"KC Anderson","year":"1985","unstructured":"Anderson KC, Boyd AW, Fisher DC, Leslie D, Schlossman SF, Nadler LM: Hairy cell leukemia: A tumor of preplasma cells. Blood 65: 620\u2013629, 1985","journal-title":"Blood"},{"key":"BF00144268_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0145-2126(86)90035-4","volume":"10","author":"V Brito-Babopulle","year":"1986","unstructured":"Brito-Babopulle V, Pittman S, Melo JV, Parreira L, Catovsky D: The 149+ marker in hairy cell leukemia. A cytogenic study of 15 cases. Leukemia Research 10: 131\u2013138, 1986","journal-title":"Leukemia Research"},{"key":"BF00144268_CR13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/aje\/121.5.675","volume":"129","author":"D Oleske","year":"1985","unstructured":"Oleske D, Golomb HM, Farber MD: A case control inquiry into the etiology of hairy cell leukemia. Am J epidemiol 129: 675\u2013683, 1985","journal-title":"Am J epidemiol"},{"key":"BF00144268_CR14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","volume":"218","author":"VS Kalyanaraman","year":"1982","unstructured":"Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Blayney D, Golde D, Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218: 571\u2013573, 1982","journal-title":"Science"},{"key":"BF00144268_CR15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1056\/NEJM198608073150606","volume":"315","author":"JD rosenblatt","year":"1986","unstructured":"rosenblatt JD, Golde DW, Wachsman W, George JV, Jacobs A, Schmidt GM, Quan S, Gasson JC, Chen ISY: A second isolate of HTLV-II associated with atypical hairy-cell leukemia. NEJM 315: 372\u2013377, 1986","journal-title":"NEJM"},{"key":"BF00144268_CR16","first-page":"7","volume":"8","author":"MR Offerman","year":"1984","unstructured":"Offerman MR, Golomb HM: Hairy cell leukemia: Current Prob Cancer 8: 7, 1984","journal-title":"Current Prob Cancer"},{"key":"BF00144268_CR17","first-page":"311","volume-title":"Important Advances in Oncology 1986","author":"HM Golomb","year":"1986","unstructured":"Golomb HM, Ratain MJ, Vardiman JW: Sequential treatment of hairy cell leukemia: A new role for interferon. In: Devita VT, Hellman S, Rosenberg SA (eds) Important Advances in Oncology 1986. J.B. Lippincott Company, Philadelphia, 1986, pp 311\u2013321"},{"key":"BF00144268_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-89-5-677","volume":"89","author":"HM Golomb","year":"1978","unstructured":"Golomb HM, Catovsky P, Golde DW: Hairy cell leukemia: A clinical review based on 71 cases. Ann Int Med 89: 677\u2013683, 1978","journal-title":"Ann Int Med"},{"key":"BF00144268_CR19","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/1097-0142(19810415)47:8<2066::AID-CNCR2820470827>3.0.CO;2-V","volume":"47","author":"J Jansen","year":"1981","unstructured":"Jansen J, Hermans J: Splenectomy in hairy cell leukemia: A retrospective multicenter analysis. Cancer 47: 2066\u20132076, 1981","journal-title":"Cancer"},{"key":"BF00144268_CR20","first-page":"370","volume":"11","author":"JW Vardiman","year":"1984","unstructured":"Vardiman JW, Golomb HM: Autopsy findings in hairy cell leukemia. Semin Oncol 11: 370\u2013380, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0002-9343(83)90616-2","volume":"74","author":"JR Quesada","year":"1983","unstructured":"Quesada JR, Keating MJ, Libshitz HI, Llamos L: Bone involvement in hairy cell leukemia. Am J Med 74: 228\u2013230, 1983","journal-title":"Am J Med"},{"key":"BF00144268_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197607222950401","volume":"295","author":"RS Seshadri","year":"1976","unstructured":"Seshadri RS, Brown EJ, Zipursky A: Leukemic reticuloen-dotheliosis. A failure of monocyte production. NEJM 295: 181\u2013184, 1976","journal-title":"NEJM"},{"key":"BF00144268_CR23","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/1097-0142(19821115)50:10<2207::AID-CNCR2820501038>3.0.CO;2-P","volume":"50","author":"WM Lee","year":"1982","unstructured":"Lee WM, Beckstead JH: Hairy cell leukemia with bone marrow hypoplasia. Cancer 50: 2207\u20132210, 1982","journal-title":"Cancer"},{"key":"BF00144268_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcp\/67.5.415","volume":"67","author":"K Nanba","year":"1977","unstructured":"Nanba K, Soban EJ, Bowling MC, Costan BW: Splenic pseudosinuses and hepatic angiomatous lesions. Distinetive features of hairy cell leukemia. Am J Clin Pathol 67: 415\u2013426, 1977","journal-title":"Am J Clin Pathol"},{"key":"BF00144268_CR25","first-page":"479","volume":"11","author":"BA Bouroncle","year":"1984","unstructured":"Bouroncle BA: The history of hairy cell leukemia: Characteristics of long term survivors. Semin Oncol 11: 479\u2013485, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-99-4-485","volume":"99","author":"HM Golomb","year":"1983","unstructured":"Golomb HM, Catovsky D, Golde DW: Hairy cell leukemia: A five-year update on seventy-one patients. Ann Intern Med 99: 485\u2013486, 1983","journal-title":"Ann Intern Med"},{"key":"BF00144268_CR27","first-page":"458","volume":"11","author":"G Flandrin","year":"1984","unstructured":"Flandrin G, Sigaux F, Sebahoun G, Bouffette P: Hairy cell leukemia: Clinical presentation and follow-up of 211 patients. Semin Oncol 11: 458\u2013471, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V60.3.571.571","volume":"60","author":"J Jansen","year":"1982","unstructured":"Jansen J, Hermans J: Clinical staging system for hairy cell leukemia. Blood 60: 571\u2013577, 1982","journal-title":"Blood"},{"key":"BF00144268_CR29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/infdis\/143.5.639","volume":"143","author":"HM Golomb","year":"1981","unstructured":"Golomb HM, Hanauer SB: Infectious complications associated with hairy cell leukemia. J Infect Dis 143: 639\u2013643, 1981","journal-title":"J Infect Dis"},{"key":"BF00144268_CR30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajh.2830160410","volume":"16","author":"HM Golomb","year":"1984","unstructured":"Golomb HM, Hadad LJ: Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 16: 393\u2013401, 1984","journal-title":"Am J Hematol"},{"key":"BF00144268_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/1097-0142(19810215)47:4<801::AID-CNCR2820470428>3.0.CO;2-6","volume":"47","author":"DJ Stewart","year":"1981","unstructured":"Stewart DJ, Bodey GP: Infectious in hairy cell leukemia. Cancer 47: 801\u2013805, 1981","journal-title":"Cancer"},{"key":"BF00144268_CR32","first-page":"514","volume":"11","author":"CA Westbrook","year":"1984","unstructured":"Westbrook CA, Golde DW: Clinical problems in hairy cell leukemia: Diagnosis and management. Semin Oncol 11: 514\u2013522, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-9343(80)90259-4","volume":"68","author":"PA Mackowiak","year":"1980","unstructured":"Mackowiak PA, Demian SE, Sutker WL, Murphy FK, Smith JW, Tompsett R, Sheehaw WW, Luby JP: Infections in hairy cell leukemia. Clinical evidence of a pronounced defect in cell mediated immunity. Am J Med 68: 718\u2013723, 1980","journal-title":"Am J Med"},{"key":"BF00144268_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000207571","volume":"62","author":"JA Child","year":"1979","unstructured":"Child JA, Cawley JC, Martin S: Microbicidal function of the neutrophils in hairy-cell leukemia. Acta Haematol 62: 191\u2013198, 1979","journal-title":"Acta Haematol"},{"key":"BF00144268_CR35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0609.1982.tb00577.x","volume":"29","author":"AJ Janckila","year":"1982","unstructured":"Janckila AJ, Wallace JH, Yam LT: Generalized monocyte deficiency in leukemic reticuloendotheliosis. Scand J Haematol 29: 153\u2013160, 1982","journal-title":"Scand J Haematol"},{"key":"BF00144268_CR36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(86)90634-0","volume":"80","author":"C Bennett","year":"1986","unstructured":"Bennett C, Vardiman J, Golomb HM: Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80: 891\u2013896, 1986","journal-title":"Am J Med"},{"key":"BF00144268_CR37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archinte.1982.00340180060014","volume":"142","author":"JK Dorsey","year":"1982","unstructured":"Dorsey JK, Penick GD: The association of hairy cell leukemia with unusual immunologic disorders. Arch Int Med 142: 902\u2013903, 1982","journal-title":"Arch Int Med"},{"key":"BF00144268_CR38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.1985.tb02835.x","volume":"61","author":"C Westbrook","year":"1985","unstructured":"Westbrook C, Golde DW: Autoimmune disease in hairy-cell leukemia: Clinical syndromes and treatment. Br J Haematol 61: 349\u2013356, 1985","journal-title":"Br J Haematol"},{"key":"BF00144268_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0140-6736(79)90294-0","volume":"ii","author":"KB Elkon","year":"1979","unstructured":"Elkon KB, Hughes GR, Catovsky D: Hairy cell leukemia with polyarteritis nodosa. Lancet ii: 280\u2013282, 1979","journal-title":"Lancet"},{"key":"BF00144268_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00320789","volume":"52","author":"F Porzolts","year":"1986","unstructured":"Porzolts F: Primary treatment of hairy cell leukemia: Should IFN therapy replace splenectomy? Blut 52: 265\u2013272, 1986","journal-title":"Blut"},{"key":"BF00144268_CR41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.292.6523.786","volume":"292","author":"D Catovsky","year":"1986","unstructured":"Catovsky D: Hairy cell leukemia: 1986. Br Med Journ 292: 786, 1986","journal-title":"Br Med Journ"},{"key":"BF00144268_CR42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0308-2261(21)00561-0","volume":"6","author":"D Catovsky","year":"1977","unstructured":"Catovsky D: Hairy cell leukemia and prolymphocytic leukemia. Clin Haematol 6: 245\u2013268, 1977","journal-title":"Clin Haematol"},{"key":"BF00144268_CR43","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/1097-0142(19851201)56:11<2557::AID-CNCR2820561103>3.0.CO;2-T","volume":"56","author":"J Magee","year":"1985","unstructured":"Magee J, McKenzie S, Filippa DA, Arlen ZA, Gee TS, Clarkson BD: Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse wih androgens in six patients. Cancer 56: 2557\u20132562, 1985","journal-title":"Cancer"},{"key":"BF00144268_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V61.2.349.349","volume":"61","author":"HM Golomb","year":"1983","unstructured":"Golomb HM, Vardiman J: Response to splenectomy in 65 patients with hairy cell leukemia. An evaluation of spleen weight and bone marrow involvement. Blood 61: 349\u2013352, 1983","journal-title":"Blood"},{"key":"BF00144268_CR45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood.V54.2.298.298","volume":"54","author":"DJ Stewart","year":"1979","unstructured":"Stewart DJ, Benjamin RS, McCredie KB, Murphy S, Keating M: The effectiveness of Rubidazone in hairy cell leukemia. Blood 54: 298\u2013304, 1979","journal-title":"Blood"},{"key":"BF00144268_CR46","first-page":"472","volume":"11","author":"J Jansen","year":"1984","unstructured":"Jansen J, denOttolander GJ, Haldrinet RSG, Tricot GJK, Hermans J: Prognosis and therapy in hairy cell leukemia. Semin Oncol 11: 472\u2013478, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198208193070805","volume":"307","author":"MA Cheever","year":"1982","unstructured":"Cheever MA, Fefer A, Greenberg PD, Applebaum FR, Armitage JO, Buckner CD, Sale GE, Storb R, Witherspoon RD, Thomas ED: Treatment of hairy cell leukemia with chemoradiotherapy and identical twin bone marrow transplantation. NEJM 307: 479\u2013481, 1982","journal-title":"NEJM"},{"key":"BF00144268_CR48","first-page":"502","volume":"11","author":"HM Golomb","year":"1984","unstructured":"Golomb HM, Schmidt K, Vardiman JW: Chlorambucil therapy of twenty-four post splenectomy patients with progressive hairy cell leukemia. Semin Oncol 11: 502\u2013506, 1984","journal-title":"Semin Oncol"},{"key":"BF00144268_CR49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1984.2.4.336","volume":"2","author":"JM Kirkwood","year":"1984","unstructured":"Kirkwood JM, Ernstoff MS: Interferons in the treatment of human cancer. J Clin Oncol 2: 336\u2013352, 1984","journal-title":"J Clin Oncol"},{"key":"BF00144268_CR50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198401053100104","volume":"310","author":"JR Quesada","year":"1984","unstructured":"Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU: Alpha interferon for induction remission in hairy-cell leukemia. NEJM 310: 15\u201318, 1984","journal-title":"NEJM"},{"key":"BF00144268_CR51","unstructured":"Ratain MJ, Vardiman JW, Golomb HM: The role of interferon in the treatment of hairy cell leukemia. Semin Oncol (in press)"},{"key":"BF00144268_CR52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1200\/JCO.1986.4.6.900","volume":"4","author":"HM Golomb","year":"1986","unstructured":"Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS, Brady J, Bonnem E, Spiegel R: Alpha-2-interferon therapy of hairy cell leukemia: A multicenter study of 64 patients. J Clin Oncol 4: 900\u2013905, 1986","journal-title":"J Clin Oncol"},{"key":"BF00144268_CR53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V68.2.493.493","volume":"68","author":"JR Quesada","year":"1986","unstructured":"Quesada JR, Hersh EM, Manning J, Reuben J, Keating M, Sohnipper E, Itri L, Gutterman JV: Treatment of hairy cell leukemia with recombinant-interferon. Blood 68: 493\u2013497, 1986","journal-title":"Blood"},{"key":"BF00144268_CR54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood.V67.3.817.817","volume":"67","author":"G Flandrin","year":"1986","unstructured":"Flandrin G, Siqaux F, Castaigne S, Billard C, Aguet M, Boiron M, Falcoff E, Degos L: Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment. Blood 67: 817\u2013820, 1986","journal-title":"Blood"},{"key":"BF00144268_CR55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(86)90705-9","volume":"80","author":"KA Foon","year":"1986","unstructured":"Foon KA, Maluish AF, Abrams PG, Wrightington S, Stevenson HC, Alarif A, Fer MF, Overton WR, Poole M, Sohnipper EF, Jaffe ES, Herberman RB: Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results. Am Jour Med 80: 351\u2013356, 1986","journal-title":"Am Jour Med"},{"key":"BF00144268_CR56","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ajcp\/85.2.194","volume":"85","author":"R Bardawil","year":"1986","unstructured":"Bardawil R, Groves C, Ratain MJ, Golomb HM, Vardiman JW: Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha-2-interferon for hairy cell leukemia. Am J Clin Pathol 85: 194\u2013201, 1986","journal-title":"Am J Clin Pathol"},{"key":"BF00144268_CR57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2141.1985.tb07480.x","volume":"60","author":"LP Worman","year":"1985","unstructured":"Worman LP, Catovsky D, Bevan PC, Cambra L, Joyner M, Green PF, Williams HJH, Bottomley JM, Gorodon-Smith EC, Cowley JC: Interferon is effective in hairy cell leukemia. Br J Haematol 60: 759\u2013763, 1985","journal-title":"Br J Haematol"},{"key":"BF00144268_CR58","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V61.6.1132.1132","volume":"61","author":"LP Ruco","year":"1983","unstructured":"Ruco LP, Procopio A, Maciallini V, Calogero A, Vocini S, Annino L, Mandeli F, Baroni CD: Severe deficiency of natural killer cell activity in peripheral blood of patients with hairy cell leukemia. Blood 61: 1132\u20131137, 1983","journal-title":"Blood"},{"key":"BF00144268_CR59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00320790","volume":"52","author":"G Gastl","year":"1986","unstructured":"Gastl G, Aulitzky W, Leiter F, Flener R, Huber C: Alphainterferon induces remissions in hairy cell leukemia without enhancement of natural killing. Blut 52: 273\u2013279, 1986","journal-title":"Blut"},{"key":"BF00144268_CR60","first-page":"4948","volume":"42","author":"EC Borden","year":"1982","unstructured":"Borden EC, Hogan TF, Voelkel JG: Comparative antipproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cell. Cancer Res 42: 4948\u20134953, 1982","journal-title":"Cancer Res"},{"key":"BF00144268_CR61","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1073\/pnas.81.6.1747","volume":"81","author":"GJ Jonak","year":"1984","unstructured":"Jonak GJ, Knight E: Selective reduction of c-myc in RNA in Daudi cells by human beta interferon. Proc Natl Acad Sci USA 81: 1747\u20131750, 1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF00144268_CR62","first-page":"4151","volume":"46","author":"BL Samuels","year":"1986","unstructured":"Samuels BL, Golomb HM, Brownstein BH: In vitro induction of proteins by alpha-interferon in hairy cell leukemia. Cancer Res 46: 4151\u20134155, 1986","journal-title":"Cancer Res"},{"key":"BF00144268_CR63","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.1984.2.12.1336","volume":"2","author":"AS Spiers","year":"1984","unstructured":"Spiers AS, Parekh SJ, Bishop MB: Hairy cell leukemia: Induction of complete response with peutostatin (2\u2032-Deoxycoformycin). J Clin Oncol 2: 1336\u20131342, 1984","journal-title":"J Clin Oncol"},{"issue":"suppli","key":"BF00144268_CR64","first-page":"698","volume":"66","author":"EH Kraut","year":"1985","unstructured":"Kraut EH, Bouroncle BA, Greever MR: Treatment of hairy cell leukemia with low dose 2\u2032-deoxycoformycin. (Abstr) Blood 66 suppli: 698, 1985","journal-title":"Blood"},{"key":"BF00144268_CR65","doi-asserted-by":"crossref","first-page":"52534","DOI":"10.1111\/j.1365-2141.1986.tb07530.x","volume":"63","author":"JB Johnston","year":"1986","unstructured":"Johnston JB, Glazer RI, Pugh L, Israels LG: The treatment of hairy cell leukemia with 2\u2032-deoxycoformycin. Br J Haematol 63: 52534, 1986","journal-title":"Br J Haematol"},{"key":"BF00144268_CR66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood.V68.1.297.297","volume":"68","author":"KA Foon","year":"1986","unstructured":"Foon KA, Nakano GM, Koller CA, Longo DL, Steis RG: Response to 2\u2032-deoxycoformycin after failure of interferon in nonsplenectomized patients with hairy cell leukemia. Blood 68: 297\u2013300, 1986","journal-title":"Blood"},{"key":"BF00144268_CR67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/1097-0142(19860701)58:1<96::AID-CNCR2820580117>3.0.CO;2-3","volume":"58","author":"AD Ho","year":"1986","unstructured":"Ho AD, Pietz G, Trede I, Schwartz R, Hoffbrand A, Hunstein W: Enzymes of purine metabolism in hairy cell leukemia. Cancer 58: 96\u201399, 1986","journal-title":"Cancer"},{"key":"BF00144268_CR68","first-page":"2179","volume":"46","author":"JB Johnston","year":"1986","unstructured":"Johnston JB, Begleiter A, Pugh L, Leith MK, Wilkins JA, Cavers DJ, Israels LG: Biochemical changes induced in hairy cell leukemia following treatment with the adenosine deaminase inhibitor 2\u2032-deoxycoformycin. Cancer Research 46: 2179\u20132184, 1986","journal-title":"Cancer Research"},{"key":"BF00144268_CR69","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V57.3.406.406","volume":"57","author":"MR Grever","year":"1981","unstructured":"Grever MR, Siaw MF, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP: The biochemical and clinical consequences of 2\u2032-deoxycoformycin in refractory lymphoproliferativc malignancy. Blood 57: 406\u2013417, 1981","journal-title":"Blood"},{"key":"BF00144268_CR70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1172\/JCI111710","volume":"75","author":"S Seto","year":"1985","unstructured":"Seto S, Carrera CJ, Kubota IT, Masson DB, Carson DA: Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to non dividing human lymphocytes. J Clin Invest 75: 377\u2013383, 1985","journal-title":"J Clin Invest"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00144268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00144268\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00144268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00144268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T21:06:04Z","timestamp":1682802364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00144268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,11]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1987,11]]}},"alternative-id":["BF00144268"],"URL":"https:\/\/doi.org\/10.1007\/bf00144268","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,11]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}